A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : HDAC

Search Conditions:
Search Keyword : HDAC
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: HDAC
Appearance Frequency: 4629 time(s)
Long forms: 33

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
histone deacetylase
(4506 times)
Neoplasms
(961 times)
TSA (518 times)
VPA (292 times)
SAHA (262 times)
1998 Role of the histone deacetylase complex in acute promyelocytic leukaemia.
high-dose cytarabine
(33 times)
Neoplasms
(16 times)
AML (22 times)
CR (13 times)
OS (6 times)
1988 Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.
histone deacetylase complex
(16 times)
Biochemistry
(4 times)
TSA (2 times)
AFR1 (1 time)
AZA (1 time)
2004 The unfolded protein response represses differentiation through the RPD3-SIN3 histone deacetylase.
high-dose Ara-C
(10 times)
Hematology
(7 times)
CR (4 times)
AML (3 times)
ALL (2 times)
1993 Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.
histone deacetylase inhibitors
(10 times)
Neoplasms
(2 times)
SAHA (2 times)
TSA (2 times)
VPA (2 times)
2008 The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear.
high-dose cytosine arabinoside
(6 times)
Neoplasms
(5 times)
AHSCT (1 time)
BUN (1 time)
CHOP (1 time)
1990 Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group study.
hydrothermal diamond anvil cell
(6 times)
Biophysics
(3 times)
4,4'-DBB (1 time)
COD (1 time)
EOS (1 time)
2004 [Evidence of discontinuous property of water: study of infrared spectra at high temperature and high pressure].
histone deacetylase activity
(5 times)
Neoplasms
(2 times)
HAT (2 times)
DNMT (1 time)
DSBs (1 time)
2000 Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
histone deacetylase enzyme
(5 times)
Physiology
(1 time)
COPD (1 time)
CRP (1 time)
CTGF (1 time)
2009 Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors.
10  histone deacetyltransferase
(5 times)
Neoplasms
(2 times)
HAT (2 times)
TSA (2 times)
5-Aza (1 time)
2005 A mechanistic approach to anticancer therapy: targeting the cell cycle with histone deacetylase inhibitors.
11  histone/protein deacetylases
(3 times)
Transplantation
(1 time)
5azaD (1 time)
FOXP3 (1 time)
HDACi (1 time)
2009 Use of epigenetic modification to induce FOXP3 expression in naive T cells.
12  High-dose acetaminophen
(2 times)
Neoplasms
(2 times)
NAC (2 times)
AFP (1 time)
MFO (1 time)
1996 Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue.
13  high-dose alkylating chemotherapy
(2 times)
Technology
(1 time)
PPV (2 times)
TNBC (2 times)
aCGH (1 time)
2015 Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy.
14  high dose alcohol consumption
(1 time)
Anxiety
(1 time)
PTSS (1 time)
2017 High dose alcohol consumption predicts less reduction in post-traumatic stress symptoms after a campus mass shooting.
15  high the dose ara-C
(1 time)
Neoplasms
(1 time)
AML (1 time)
DFS (1 time)
LDAC (1 time)
2011 The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine.
16  high-dose Ara-c group
(1 time)
Hematology
(1 time)
AML (1 time)
Ara-c (1 time)
LDAC (1 time)
2016 Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China.
17  high-dose Ara-C treatment
(1 time)
Hematology
(1 time)
ALL (1 time)
CRP (1 time)
NHL (1 time)
2005 Ara-C fever and infections after high-dose ara-C treatment in pediatric lymphoid malignancies.
18  high-dose ara-C-based chemotherapy
(1 time)
Hematology
(1 time)
APL (1 time)
ATRA (1 time)
molCR (1 time)
2007 Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
19  high-dose arabinosyl cytosine
(1 time)
Hematology
(1 time)
ALL (1 time)
ANLL (1 time)
CR (1 time)
2002 Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
20  high-dose cytarabine chemotherapy
(1 time)
Hematologic Diseases
(1 time)
allo-SCT (1 time)
CN (1 time)
FLT3-ITD (1 time)
2010 Prognostic significance of nucleophosmin mutations and FLT3 internal tandem duplication in adult patients with cytogenetically normal acute myeloid leukemia.
21  high-dose cytarabine consolidation
(1 time)
Neoplasms
(1 time)
AML (1 time)
CBF (1 time)
CIR (1 time)
2008 Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.
22  High-dose cytosine arabinoside or ARA-C
(1 time)
Neoplasms
(1 time)
--- 1993 Documentation of neurotoxicity resulting from high-dose cytosine arabinoside.
23  high-dose cytosine-arabinoside/daunorubicin
(1 time)
Medicine
(1 time)
BMT (1 time)
DAV (1 time)
1996 [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
24  histone acetylase and deacetylase
(1 time)
Biochemistry
(1 time)
ds (1 time)
2009 Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase.
25  histone acetyltransferases and deacetylases
(1 time)
Biochemistry
(1 time)
GFP (1 time)
2004 Potent stimulation of gene expression by histone deacetylase inhibitors on transiently transfected DNA.
26  Histone deacetylase inhibitors
(1 time)
Molecular Biology
(1 time)
TSA (1 time)
2015 Effect of HDAC Inhibitors on Corneal Keratocyte Mechanical Phenotypes in 3-D Collagen Matrices.
27  histone deacetylase superfamily
(1 time)
Molecular Biology
(1 time)
DCHA (1 time)
QM/MM (1 time)
2018 Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations.
28  histone deacetylases 1-3
(1 time)
Respiratory Tract Diseases
(1 time)
ASM (1 time)
TNF-alpha (1 time)
VDR (1 time)
2016 Vitamin D Reduces Inflammation-induced Contractility and Remodeling of Asthmatic Human Airway Smooth Muscle.
29  histone deacetyltransferase activity
(1 time)
Neurology
(1 time)
CBP (1 time)
RTS (1 time)
2004 Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.
30  histone NAD-dependent deacetylase
(1 time)
Medical Informatics
(1 time)
HDACs (1 time)
SDP (1 time)
SMC (1 time)
2005 Proteins with two SUMO-like domains in chromatin-associated complexes: the RENi (Rad60-Esc2-NIP45) family.
31  histone-acetylation and -deacetylation
(1 time)
Pharmacology
(1 time)
HDACIs (1 time)
2015 [EPIGENETIC ENZYMES AS THERAPEUTIC TARGETS FOR TREATING BRAIN DISORDERS].
32  hyperdynamic airway collapse
(1 time)
Allergy and Immunology
(1 time)
TBM (1 time)
2013 Tracheomalacia/Tracheobronchomalacia and hyperdynamic airway collapse.
33  microbe-histone deacetylase
(1 time)
Environmental Microbiology
(1 time)
GPR (1 time)
NFC (1 time)
SCFAs (1 time)
2017 Associations among dietary non-fiber carbohydrate, ruminal microbiota and epithelium G-protein-coupled receptor, and histone deacetylase regulations in goats.